Table 5.
Performance characteristics of TLC and HPTLC methods.
| S.No. | Stationary phase; Mobile phase | Detection (nm) | Linear range (µg/spot) | LOD (µg/spot) | LOQ (µg/spot) | Application | Reference |
| 1 | Spectrodensitometry | 283 | 5–25 | – | – | Pharmaceutical preparations containing TFH and triamcinolone | [16] |
| 2 | Silica gel 60F254; 25% aqueous ammonia–chloroform–methanol (0.1:12:0.1, v/v/v) | 284 | – | – | – | Bulk drug, degradation products | [35] |
| 3 | Silica gel 60F254; Formic acid-toluene–ethylacetate (0.1:4.5:5.5, v/v/v) | 284 | – | – | 0.035 | Pharmaceuticals, accelerated stability testing | [39] |
| 4 | Silica gel 60F254; n-hexane: acetone: glacial acetic acid (8:2:0.1, v/v/v) | 223 | 0.2–1 | 0.0012 | 0.0036 | Bulk drug and tablets; SIAM | [40] |
| 5 | Silica gel 60F254; acetonitrile: 1,4-dioxane: hexane: acetic acid (1:1:8:0.1, v/v/v/v) | 282 | 0.5–5 | 0.30 | 0.39 | Tablets | [41] |
SIAM: Stability-indicating assay method.